Pharmacokinetics of gallium nitrate after oral administration in adult horses–pilot study.

The study explores how gallium nitrate, a substance that can inhibit bone loss, is absorbed and eliminated in adult horses when orally administered. The results may help in treating bone diseases in sport horses.

Understanding the Research

• The study is based on gallium nitrate, a substance that contains the metal gallium. Gallium has previously demonstrated activity against bone resorption. Bone resorption is a process where bone tissue is broken down. This indicates that gallium could potentially be useful in treating certain diseases related to bones, such as navicular disease, in sports horses.
• Specifically, the study aimed to understand the kinetics of gallium. This refers to how the substance is absorbed, metabolized, distributed in the body, and eventually eliminated.

The Experiment

• The research involved six adult horses, which were each administered a single oral dose of 10 mg/kg of gallium nitrate mixed with their food.
• The scientists then observed the absorption and excretion of the substance in the horses. Absorption was noted to be slow, with a Tmax (time to achieve maximum plasma concentration) of 10 ± 3 hours and a T½abs (absorption half-life, or the time for the drug concentration in the body to reduce to half its initial value after absorption) of 2 ± 0.8 hours.
• The maximum concentration achieved in the horse’s bloodstream was 26 ± 11 µg/L.
• The excretion of Gallium nitrate followed a one-phase elimination model, having a long half-life (time taken for the drug concentration in the body to reduce to half through elimination) of 52 ± 14 hours.

Implications and Future Work

• Based on a mathematical model, the researchers estimated that repeated daily administration of the same dosage (10 mg/kg of gallium nitrate) should theoretically lead to a plasma concentration of 93 µg/L at steady state.
• This is significant because previous studies have shown that a concentration three times lower than this was effective in inhibiting the activity of osteoclasts, cells that break down bone tissue, in a laboratory setting. This implies that the dosage used in this study could potentially be effective in a biological system as well.
• From these findings, the researchers suggest that the administration of oral gallium nitrate at a rate of 10 mg/kg per day may be considered for future clinical studies in the treatment of bone diseases in horses.